Tradestie Institutional Equity Comparison Engine

PROK vs CVM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PROK Overall Edge

PROK Captures Institutional Edge (3โ€“1 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ProKidney Corp. Class A Ordinary Shares (PROK) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation. Fundamentally, PROK trades at N/M Forward P/E with -24830.3% operating margin (-19.8% YoY revenue) versus CVM at 23.0x Forward P/E and 0.0% operating margin (-62.7% YoY). In options structure, PROK sits in BREAKDOWN (42nd %ile IV; Dealer Gamma Walls on Pro) against CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CVM
PROK N/M vs CVM 23.0x Fwd P/E
Growth & Margin Winner PROK
Op Margin -24830.3% vs 0.0% ยท YoY -19.8% vs -62.7%
Momentum & Technical Winner PROK
1Y -55.0% vs -77.5% ยท 52W Pos 9% vs 10%
Options & Structure Winner PROK
BREAKDOWN (42nd %ile IV) vs BREAKDOWN (N/A IV)
PROK NASDAQ
ProKidney Corp. Class A Ordinary Shares
Biological Products, (No Disgnostic Substances)
$1.02
-1.91% 1D
Market Cap $415.2M
1M Return -22.93%
1Y Return -55.04%
Forward P/E N/M
Unified AI Score
64.1 / 100 BUY
Tech 76.0 Fund 52.0 Flow 68.0 Mom 60.0
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap $20.9M
1M Return -11.17%
1Y Return -77.48%
Forward P/E 23.0x
Unified AI Score
56.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PROK -55.04% CVM -77.48% Spread: +18.51 pp (PROK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PROK Revenue CVM Revenue PROK Op. Margin CVM Op. Margin Margin Edge
FY2011 N/A $0M N/A -1881.0% CVM
FY2012 N/A $0M N/A -6772.3% CVM
FY2013 N/A $0M N/A -12450.1% CVM
FY2014 N/A $0M N/A -9721.4% CVM
FY2024 $0M N/A -241678.9% N/A PROK
FY2025 $0M N/A -18477.8% N/A PROK

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PROK (5) vs CVM (4)
Institutional Metric PROK CVM Criterion Row Winner
Market Capitalization Scale $415.2M $20.9M Larger Scale PROK
Trailing P/E Ratio Valuation N/M 23.0x Lower Multiple CVM
Forward P/E Ratio Valuation N/M 23.0x Lower Multiple CVM
Revenue Growth (YoY) Growth -19.8% -62.7% Higher Growth PROK
Operating Margin (TTM) Profitability -24830.3% 0.0% Higher Margin CVM
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -73.4% -252.5% Higher ROE PROK
52-Week Range Position Momentum 9% ($1โ€“$3) 10% ($1โ€“$8) Stronger Trend CVM
Beta / 30D Volatility Risk Regime 1.71ฮฒ ยท 92% Vol 0.65ฮฒ ยท 120% Vol Lower Realized Risk PROK
Unified Institutional Score Composite Signal 64.1 / 100 (BUY) 56.6 / 100 (HOLD) Higher Composite PROK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PROK vs CVM Buy Guide
PROK BREAKDOWN
50d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 42nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live PROK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CVM BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PROK nor CVM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.